Literature DB >> 11969233

Epidemiology and screening of colorectal cancer.

Jean Faivre1, Anne-Marie Bouvier, Claire Bonithon-Kopp.   

Abstract

Knowledge of the descriptive epidemiology of colorectal cancer is essential to a better understanding of the aetiology of the disease and the development of screening strategies. Considerable research efforts have been launched over the last 15 years to evaluate the ability of screening tests to decrease the incidence and mortality of colorectal cancer. This chapter provides a worldwide update of the incidence of colorectal cancer and reviews the evidence for screening for colorectal cancer based on published studies. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 11969233     DOI: 10.1053/bega.2001.0280

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  17 in total

1.  Colorectal cancer screening: physicians' knowledge of risk assessment and guidelines, practice, and description of barriers and facilitators.

Authors:  Maida J Sewitch; Pascal Burtin; Martin Dawes; Mark Yaffe; Linda Snell; Mark Roper; Patrizia Zanelli; Alan Pavilanis
Journal:  Can J Gastroenterol       Date:  2006-11       Impact factor: 3.522

Review 2.  Screening for colorectal cancer using the faecal occult blood test, Hemoccult.

Authors:  P Hewitson; P Glasziou; L Irwig; B Towler; E Watson
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

3.  Metabolic syndrome is associated with increased prevalence of advanced colorectal polyps.

Authors:  S Tal; E Melzer; T Chsherbakov; S Malnick
Journal:  J Nutr Health Aging       Date:  2014-01       Impact factor: 4.075

4.  Radiation induced rectal cancer: a case report with review of the literature.

Authors:  Mustapha Dahiri; Nariman Salmi; Anas Ahallat; Nezha El Bahaoui; Omar Belkouchi; Amine Souadka; Anas Majbar; Amine Benkabbou; Abdeslam Bougtab; Raouf Mohsine
Journal:  AME Case Rep       Date:  2018-06-14

5.  Phase II trial of fortnightly irinotecan (CPT-11) in the treatment of colorectal cancer patients resistant to previous fluoropyrimidine-based chemotherapy.

Authors:  Carlos García-Girón; Andrés García Palomo; Carmen Alonso López; Angel León Carbonero; Miguel Méndez Ureña; Encarna Adróver Cebrián; Ramón Barceló Galíndez; Mónica Arroyo Yustos; José Alvarez Gallego
Journal:  Clin Transl Oncol       Date:  2005-07       Impact factor: 3.405

6.  Insulin therapy and the risk of colorectal cancer in patients with type 2 diabetes: a meta-analysis of observational studies.

Authors:  Wu-jie Bu; Lei Song; Dan-yi Zhao; Bing Guo; Jing Liu
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

7.  Perceptions of knowledge, beliefs, and barriers to colorectal cancer screening.

Authors:  Richard Stacy; William Alvin Torrence; Carol R Mitchell
Journal:  J Cancer Educ       Date:  2008       Impact factor: 2.037

8.  Past, present and future of colorectal cancer in the Kingdom of Saudi Arabia.

Authors:  Ezzeldin M Ibrahim; Ahmed A Zeeneldin; Tawfik R El-Khodary; Aboelkhair M Al-Gahmi; Bakr M Bin Sadiq
Journal:  Saudi J Gastroenterol       Date:  2008-10       Impact factor: 2.485

9.  Patient-identified quality indicators for colonoscopy services.

Authors:  Maida J Sewitch; Catherine Dubé; Stephanie Brien; Mengzhu Jiang; Robert J Hilsden; Alan N Barkun; David Armstrong
Journal:  Can J Gastroenterol       Date:  2013-01       Impact factor: 3.522

10.  [Radiofrequency ablation (RFA) of lung metastases from colorectal cancer (CRC)-one-year follow-up].

Authors:  K Steinke; J King; D Glenn; D L Morris
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.